QUICK LINKS
MAIN MENU
CONNECT WITH US

Clinical Trials

Search Clinical Trials By:

-- Select One --

Showing 1 to 3 of 3
<<
1 - 3
>>
Clinical Trials
A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 52-Week Treatment Period as an Early Intervention in Patients with Attenuated Psychosis Syndrome
ALK3831-A307: A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness
Protocol: ALK3831-A308 A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects with Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder

Resources

News & Announcements

Upcoming Events

Oct 29

NIH SBIR Grant Funding Workshop

From 10:00 AM until 5:00 PM

Nov 5